‘At the Limits’ is leading medical education; enabling leading academics, scientists, researchers, specialists and clinicians to meet in inspiring and stimulating academic environments. The meetings are supported by Industry and we encourage supporters to attend with a delegation of senior medical personnel to build and maintain the relationships between medicine and industry which are so essential for the development and understanding of successful patient care.
Meetings take place throughout the year, across the globe, with upcoming events on London, Cape Town, Shenzhen and Singapore
Please register to be kept informed of upcoming meetings.
*CDNATL 2015 & 2016 delegate feedback surveys
New for 2017
On Monday 20th & Tuesday 21st November 2017 a world class faculty of MS research pioneers will convene in London to present at the first annual Multiple Sclerosis at the Limits conference. The Chairs, Professor Gavin Giovannoni (Bart’s, London) and Professor William Carroll (University of Western Australia) have developed an outstanding programme which is sure to attract an expert audience of MS professionals from across the UK and beyond. Places are strictly limited by room size, and as with all ‘At the Limits’ meetings, this event is likely to quickly become oversubscribed. Click here for more information and to express interest in attending.
New for 2017
Following the highly successful ACI meeting in London in May 2017, the event will hold a satellite to the ESMO ASIA conference in November 2018. Chaired by Professor Chng Wee Joo, Director of the National University Cancer Institute, Singapore (NCIS), and Dr Sergio Quezada (UCL Cancer Institute, London) the 1.5 day meeting will bring together global and local experts in Cancer Immunotherapy for, what promises to be a highly informative and enjoyable event. Register your interest in attending.
New for 2017
Professors Derek Yellon (UCL) & Sir John Cunningham (UCL) and Dr Sarah Linklater (The Lancet) present the 2017 Hatter Cardiovascular Institute Horizon conference on Monday 27th November at the Royal College of Physicians in London. Concentrating on the exciting new treatment options around GLP-1 & SGLT-2 inhibitors, the conference will consider developments at the cutting edge of cardio-metabolic treatment. Click here for more information and to pre-register.
Continuing in 2018
A full programme of events is scheduled for 2018. Continuing events include:
Accelerating Cancer Immunotherapy Europe 2018
Tuesday 8th and Wednesday 9th May 2018
Accelerating Cancer Immunotherapy will be held in London in May 2018. Again led by Dr Sergio Quezada (UCL) and Professor Padmanee Sharma (MD Anderson), Europe’s largest independent cancer immunotherapy conference is set to continue exceeding expectations as a host of world class speakers convene at the Royal College of Physicians. 2017 was quickly oversubscribed and 2018 is likely to sell out fast. To register your interest in attending click HERE, and you’ll be amongst the first to know when full registration is open.
Cardiology, Diabetes & Nephrology at the Limits XX
Monday 9th - Wednesday 11th April 2018
The annual CDNATL meeting takes place in London during April 2018. Celebrating it’s 20th anniversary, the meeting will consider the changes in treatment options which are becoming available, and examine the long-term development of groundbreaking discoveries which are shaping the cardio-metabolic landscape.
Oncology at the Limits VIII
Monday 19th - Wednesday 21st March 2018
For a decade, Oncology at the Limits has been a leading international conference in the field of early phase scientific discovery. As cancer immunotherapies and personalised treatment become more established, the Chairs: Professor Tariq Enver (UCL Cancer Institute), Professor Daniel Hochhauser (UCL Cancer Institute) & Dr Roy Herbst (Yale Cancer Centre) will lead a faculty of scientific and industry speakers, to discuss and debate leading edge research and development.
New for 2019
Cardiology, Diabetes & Nephrology at the Limits South America
The hugely successful Cardiology, Diabetes & Nephrology at the Limits meeting, which has been held in the UK and South Africa for over 20 years, is adding a new event in 2019, in San Paulo, Brazil. Professors Derek Yellon, John Cunningham and Drs Peter Libby and Marc Pfeffer have designed a programme which brings together the leading international researchers in these closely linked disease areas, with regional experts who are at the forefront of treatment. We’ll formerly launch the event in early 2018, so check back for more details.